Factors Associated with a Positive Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Suspected Cases Presenting with Pneumonia: A Retrospective Cohort Study in a Single Medical Center

Author:

Li Yupeng,Shang Yu,Yang Yi,Wang Menghan,Yu Dongping,Su Dongju,Liu Lei,Wang Qin,Zhang Xiaona,Ren Juan,Chen Hong

Abstract

<b><i>Background:</i></b> Coronavirus disease 2019 (COVID-19) has become a global emerging infectious disease. <b><i>Objectives:</i></b> To analyze the initial clinical characteristics of COVID-19 suspected and confirmed patients on admission in order to find out which kinds may be more likely to get positive nucleic acid testing results, and to explore the risk factors associated with all-cause death. <b><i>Methods:</i></b> Medical records from 309 highly suspected cases with pneumonia were collected from February 13, 2020, to March 14, 2020, in a COVID-19-designated hospital of Wuhan. The majority of the clinical data were collected on the first day of hospital admission. <b><i>Results:</i></b> Of 309 patients with median age 64 years (interquartile ranges [IQR], 53–72 years), 111 patients (35.9%) were confirmed by nucleic acid testing (median age 64 years, IQR: 56–71 years; 48 males). Of those 111 patients, 13 (11.7%) patients died. In multivariate analysis, factors associated with positive testing included fatigue (odds ratios [OR] = 3.14; 95% confidence interval [CI]: 1.88–5.24, <i>p</i> &#x3c; 0.001), cough (OR = 0.55; 95% CI: 0.32–0.95, <i>p</i> = 0.032), no less than 1 comorbidity (OR = 1.77; 95% CI: 1.06–2.98, <i>p</i> = 0.030), and severe pneumonia (OR = 2.67; 95% CI: 1.20–5.97, <i>p</i> = 0.016). Furthermore, age, dyspnea, noneffective antibiotic treatment, white blood cell, lymphocyte, platelets, and organ dysfunction (e.g., higher lactate dehydrogenase) were significantly associated with all-cause in-hospital death in patients with COVID-19. <b><i>Conclusion:</i></b> Patients with severe forms of this disease were more likely to get positive results. Age and organ dysfunction were associated with a greater risk of death.

Publisher

S. Karger AG

Subject

Pulmonary and Respiratory Medicine

Reference10 articles.

1. Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020 Mar;579(7798):265–9.

2. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.

3. Viasus D, Marinescu C, Villoslada A, Cordero E, Gálvez-Acebal J, Fariñas MC, et al. Community-acquired pneumonia during the first post-pandemic influenza season: a prospective, multicentre cohort study. J Infect. 2013 Sep;67(3):185–93.

4. Laqmani A, Adam G, Regier M. Pulmonary manifestation of novel swine-origin influenza A (H1N1) virus (S-OIV) infection in immunocompromised patients: initial findings with multidetector computed tomography. Med Princ Pract. 2012;21(6):548–53.

5. Chandler TM, Leipsic J, Nicolaou S, Quiney B, Romney M, Müller NL, et al. Confirmed swine-origin influenza A(H1N1) viral pneumonia: computed tomographic findings in the immunocompetent and the immunocompromised. J Comput Assist Tomogr. 2011 Sep–Oct;35(5):602–7.

Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3